Roche Holding AG (SWX:RO)
287.60
-7.20 (-2.44%)
Apr 4, 2025, 10:46 AM CET
Roche Holding AG Revenue
In the year 2024, Roche Holding AG had annual revenue of 62.40B CHF with 3.23% growth. Roche Holding AG had revenue of 31.64B in the half year ending December 31, 2024, a decrease of -0.86%.
Revenue
62.40B
Revenue Growth
+3.23%
P/S Ratio
n/a
Revenue / Employee
604.32K
Employees
103,249
Market Cap
223.26B
Revenue Chart
Revenue History
Fiscal Year End | Revenue | Change | Growth |
---|---|---|---|
Dec 31, 2024 | 62.40B | 1.95B | 3.23% |
Dec 31, 2023 | 60.44B | -5.37B | -8.16% |
Dec 31, 2022 | 65.81B | -36.00M | -0.05% |
Dec 31, 2021 | 65.85B | 5.51B | 9.13% |
Dec 31, 2020 | 60.34B | -3.41B | -5.35% |
Dec 31, 2019 | Pro | Pro | Pro |
Dec 31, 2018 | Pro | Pro | Pro |
Dec 31, 2017 | Pro | Pro | Pro |
Dec 31, 2016 | Pro | Pro | Pro |
Dec 31, 2015 | Pro | Pro | Pro |
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionRelated Stocks
Company Name | Revenue |
---|---|
Roche Holding AG | 62.40B |
Novartis AG | 46.87B |
Alcon | 8.98B |
Lonza Group AG | 6.57B |
Galderma Group AG | 4.02B |
Straumann Holding AG | 2.50B |
Sandoz Group AG | 9.41B |
Sonova Holding AG | 3.71B |
Roche Holding AG News
- 14 hours ago - Sarepta/Roche Suspend Elevidys Gene Therapy Trials In Europe After Patient Death - Benzinga
- 14 hours ago - Sarepta/Roche Suspend Elevidys Gene Therapy Trials In Europe After Patient Death - Benzinga
- 20 hours ago - Roche presents novel therapeutic and diagnostic advancements in Alzheimer's at AD/PD 2025 - GlobeNewsWire
- 20 hours ago - Genentech and Roche Present Novel Therapeutic and Diagnostic Advancements in Alzheimer's at AD/PD 2025 - Business Wire
- 23 hours ago - Pharma tariff relief likely short-lived with sector-specific duties on the horizon - CNBC
- 1 day ago - Why Is Pharma Giant Roche Stock Trading Lower On Wednesday? - Benzinga
- 1 day ago - Why Is Pharma Giant Roche Stock Trading Lower On Wednesday? - Benzinga
- 1 day ago - IBD 50 Stock TG Therapeutics Rallies On A Setback For Chief Rival Roche - Investor's Business Daily